September 5, 2019 - Blogs & Articles

BMS, Takeda, Celgene, Boehringer-Ingelheim & Biogen will Speak at 2nd Annual MarketsandMarkets Real-World Data & Life Science Analytics Congress

September 5, 2019September 5, 2019 MarketsandMarkets Conferences

Boston, USA, 5th September – 2nd Annual MarketsandMarkets Real-World Data & Life Science Analytics Congress will be hosting industry giants like Bristol Myers Squibb, Takeda, Genentech, Boehringer-Ingelheim, Celgene and Biogen will take place at the DoubleTree by Hilton Boston-Downtown on 25th & 26th October 2019. Presenting 20+ RWD case studies, the congress aims to discuss accelerating the adoption of Real-world Evidence, capabilities of newer technologies for evidence generation within the industry. The event agenda will focus on key aspects such as Real-World Evidence Methodologies, FDA’ strategic framework, Applications of Artificial Intelligence…

Technologies Transforming Real-World Evidence (RWE) Evidence in the Pharmaceutical Industry

September 5, 2019September 5, 2019 MarketsandMarkets Conferences

As new drugs are emerging every day, it is very important to ensure that the patients get right and effective treatment. One such step can be taken from Real World Evidence (RWE). In simple words, Real World Evidence means data and information collected outside of a clinical trial. This data can be electronic medical records, medical charts or other medical claims to assess patient outcomes. It is made sure that the patient’s identity is removed from the previous data to maintain the patient’s privacy. However, today’s real-world evidence data is…